Project Grant R21EB038753
- The National Institutes of Health National Cancer Institute awarded the University of California, Los Angeles $761,691 on June 15, 2026, under the Cancer Detection and Diagnosis Research program (CFDA 93.394) to conduct a prospective randomized controlled trial evaluating the impact of artificial intelligence on breast cancer screening quality and effectiveness in 3D mammography. The study will assess the comparative effectiveness of mammography interpretation with versus without FDA-cleared...
- The National Cancer Institute awarded the University of California, Los Angeles $640,956 on May 15, 2026, under the Cancer Detection and Diagnosis Research program (CFDA 93.394) to develop an artificial intelligence-enhanced perfusion MRI imaging biomarker for predicting yttrium-90 microsphere distribution in radioembolization treatment of liver cancer. The project addresses the current limitation that determining how Y90 microspheres disperse in a tumor relies on labor-intensive tracking of...
- The National Institutes of Health Office of the Director awarded the University of California, Los Angeles $200,000 on July 1, 2026, under the Trans-NIH Research Support program (CFDA 93.310) to establish governance and infrastructure for rapid, reproducible evaluation of artificial intelligence tools developed for Alzheimer's disease and related dementias populations. UCLA will develop the APEX-ADRD (Accelerating Platforms for Evaluating and Executing AI Lifecycles in ADRD) collaboratory, a...
- The Department of Health and Human Services National Institutes of Health Office of the Director awarded The Leland Stanford Junior University $731,500 on September 1, 2026, under the Trans-NIH Research Support program (CFDA 93.310) to develop physics-informed machine learning systems for medical image analysis. The project will build a generative simulation environment that models dynamic human anatomy and physiology to produce realistic synthetic imaging data such as radiographs and CT scans...
- The National Institute of General Medical Sciences awarded $433,125 to the University of California, Los Angeles on August 10, 2026, under the Biomedical Research and Research Training program (CFDA 93.859, Assistance Listing). Andrew Holbrook, a biostatistician at UCLA, will develop AI-accelerated inference strategies and open-source software for Bayesian hierarchical models applied to high-impact biostatistical problems. The work addresses a computational bottleneck in biomedical research:...
- The National Institute of Biomedical Imaging and Bioengineering awarded the University of California, Los Angeles $174,861 on March 10, 2026, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to support development and external validation of machine learning algorithms that predict pediatric postoperative complications using physiologic waveform and electronic health record data. The award funds career development and...
- Federal Project Grant Award Summary The National Institute of Biomedical Imaging and Bioengineering awarded $630,000 to the University of California, Los Angeles under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) on September 1, 2025, with a completion date of August 31, 2028. This three-year project develops light-activated site-specific conjugation (LASIC) technology to advance the clinical translation of catheter-directed...
- The National Institute of Biomedical Imaging and Bioengineering awarded $414,079 to the University of North Carolina at Chapel Hill on June 1, 2026, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286, R21 mechanism) to develop factual medical large vision-language models for radiology that reduce hallucinations in AI-generated medical image analyses. The project addresses hallucinations in medical large vision-language models...
- The National Institute of Biomedical Imaging and Bioengineering awarded the Regents of the University of Minnesota $1,364,828 on April 1, 2026, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to conduct research on safe, effective, and trustworthy artificial intelligence deployment across U.S. healthcare delivery organizations. The project uses mixed methods to identify barriers to and mitigation strategies for AI capability...
- This $1,434,445.00 Project Grant award from the National Institutes of Health's Trans-NIH Research Support program (CFDA 93.310) supports the University of Southern California (USC) in developing new deep learning-based architectures, algorithms and training mechanisms to address key challenges in magnetic resonance imaging (MRI) reconstruction. The project aims to create a robust, reliable and trustworthy toolkit for reducing MRI acquisition time, enabling high-quality reconstruction with...
The National Institute of Biomedical Imaging and Bioengineering awarded the University of California, Los Angeles $244,897 on August 18, 2026, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to develop and validate AI approaches that enhance transparency and clinical generalizability of foundation models in radiology imaging diagnostics. The project focuses on lung disease detection on chest X-rays using two specific approaches: integrating clinically interpretable concepts to improve model transparency through concept embeddings, and studying model-editing methods to enhance performance on rare pathologies. The work addresses gaps in understanding medical foundation models by auditing and curating expert-driven concept sets for radiological findings and examining approaches to improve model reliability on long-tailed pathologies, all without requiring full model retraining. The methodologies are designed to be disease and image agnostic, with potential application beyond the initial lung-imaging focus. Work is performed at UCLA in Los Angeles, California, with a period of performance through July 31, 2028. The award is a Project Grant supporting exploratory and developmental research in response to PA-25-304.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $244.9k | 8/18/26 |